Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice

Abstract

BackgroundRecently, we found that the probiotic strain Bacillus coagulans GBI-30, 6086 (GanedenBC30) improved indices of Clostridium difficile (C. difficile)-induced colitis in mice (Fitzpatrick et al., Gut Pathogens, 2011). Our goal was to determine if BC30 could also prevent the recurrence of C. difficile-induced colitis in mice, following initial treatment with vancomycin. During study days 0 through 5, mice were treated with antibiotics. On day 6, the C. difficile strain VPI 10463 was given by oro-gastric gavage at ≈ 5x104 CFU to induce colitis. Mice were treated on study days 6 to 10 with vancomycin (50 mg/kg) (vanco) or vehicle (saline) by gavage. On days 10 to16, mice were dosed by gavage with saline vehicle or BC30 (2 x 109 CFU per day). Mice were monitored for mortality, weight loss and diarrhea. On study days 14, 16 and 17, stools and colons were collected for analyzing other parameters of colitis.ResultsThe mean stool consistency score in Vehicle/C.difficile/Vanco mice increased from 0.4 (day 10) to a range of 1.1 to 1.4 (days 14 to 17), indicating the recurrence of colitis. On days 13 through 17, the stool consistency scores for the vancomycin/BC30 mice were significantly lower (p< 0.05) than for the vancomycin/vehicle cohort of animals. On day 17, 88.9% of mice treated with BC30 had normal stools, while this value was 0% with vehicle treatment (p value = 0.0004). Colonic myeloperoxidase (Units/2 cm colon) was significantly (p < 0.05) reduced from 4.3 ± 0.7 (Vehicle/C.difficile/Vanco) to 2.6 ± 0.2 (BC30/C. Difficle/Vanco). The colonic histology score and Keratinocyte derived-chemokine level in the colon were also lower in BC30 treated mice.SummaryIn BC30-treated mice, there was evidence of better stool consistency, as well as improved biochemical and histological indices of colitis, following initial treatment of animals with vancomycin.ConclusionBC30 limited the recurrence of CD-induced colitis following vancomycin withdrawal in mice.

Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome

“…Quite a number of species of Clostridium can be pathogenic and have been correlated with colitis, enteritis, and food poisoning. [34][35][36][37] The fact that Clostridium was enriched in Vdr À/À fecal stool therefore potentially increased the risks for gut disorders. Alistipes, Odoribacter, and Eggerthella were altered in the cecal stool of Vdr -/-mice.…”

Fecal imaging demonstrates that low-methoxyl pectin supplementation normalizes gastro-intestinal transit in mice given a liquid diet

“…The composition of the liquid diet and the pectin content were the same as the product (Hine E-gel; Otsuka Pharmaceutical Factory) used for human enteral feeding. As described in Study 1, 0.1 mL of ICG solution was administered at around 09:00 and fecal pellets were subsequently collected for 8 h under withdrawal of food and water, with recording of collection times and scores for fecal consistency (Score 0, normal; Score 1, loose stool; Score 2, loose/some diarrhea; Score 3, diarrhea) (Fitzpatrick et al 2012).…”

Recovery of Viable Bacteria from Probiotic Products that Target Oral Health

“…One brand included the species Bacillus coagulans which holds promise as an intestinal probiotic to prevent Clostridium difficile colitis [13] and for its immunomodulatory effects [14]. All were expected to grow on the blood agar.…”